Maze Therapeutics, Inc. (MAZE) vs Taysha Gene Therapies, Inc. (TSHA)
Maze Therapeutics, Inc. and Taysha Gene Therapies, Inc. are both Biotechnology companies. Maze Therapeutics, Inc. and Taysha Gene Therapies, Inc. are of similar size ($1.6B and $1.5B). Across the 10 metrics below, Maze Therapeutics, Inc. leads on 7 and Taysha Gene Therapies, Inc. on 3.
Valuation
Profitability
| Metric | MAZE | TSHA | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (37.35%) | (47.05%) | (57.72%) |
| Return on assets | (31.99%) | (37.23%) | (49.22%) |
| Return on invested capital | (112.36%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack